Atlas Trials

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

Clinical trial NCT06603246 · RECRUITING

Trial details

NCT number
NCT06603246
Sponsor
Genentech, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Non-cystic Fibrosis BronchiectasisChronic Obstructive Pulmonary Disease
Start date
2024-11-18
Primary completion
2027-11-15
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.